Medical imaging software developer MIM Software has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for post-treatment dosimetry of yttrium-90 (Y-90) microspheres. MIM SurePlan LiverY90 provides tools for liver and tumor segmentation, deformable registration, and patient-specific dose calculation on Y-90 PET and Bremsstrahlung SPECT images after permanent Y-90 microsphere implant administration. {read more here}